This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
Kidney Cancer
RadiCal
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
ECLIPSE
FORT
NRG-GU 0101
Oral EPI-7386
RTIRE
SHORTER
SPLASH
Right Side
PCCTC
DORA
IRONMAN
PROMISE
Centers of Excellence
Urologic Oncology
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Translational Prostate Cancer
Andrea Miyahira, Ph.D
Left Group
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Trimodality Therapy
Leslie Ballas, MD
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
EnDOUROLOGY
Sumanta (Monty) Kumar Pal, MD||Jaime Landman, MD
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Health Policy
Ruchika Talwar, MD
WOMEN IN SCIENCE
Andrea Miyahira, Ph.D
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Suprapubic Catheter
Diane K. Newman, DNP FAAN BCB-PMD
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Education
Covid-19
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Pelvic
Pelvic Health & Reconstruction
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
ASTRO 2023
SNMMI 2023
ProsTIC/PCF Global Webinar 2023
ASCO 2023
AUA 2023
All Conferences
View All
PCF
UroToday Home
Conference Highlights
SES AUA 2022
SES AUA 2022
SESAUA 2022 Prostate Cancer
SESAUA 2022 Bladder Cancer
SESAUA 2022 Upper Tract Urothelial Carcinoma
SES AUA 2022 Bladder Cancer
Viewing 1-6 of 6 articles
SES AUA 2022: Prolonged Opioid Use Following TURBT: Insurance Claims Review of High-Risk Prescribing to Opioid-Naive Patients
SES AUA 2022: Gender Disparities in the Clinical Trials and Real-World Utilization of Systemic Therapy in the Management of Urothelial Carcinoma
SES AUA 2022: Preliminary Results Of A Single Arm Phase II Trial Of Intraoperative Intravesical Mitomycin C During Nephroureterectomy For Urothelial Carcinoma
SES AUA 2022: Extramural Venous Invasion: A Novel Magnetic Resonance Imaging Biomarker For Adverse Pathology In Bladder Cancer
SES AUA 2022: Association Between Visibly Complete TURBT and Pathologic Downstaging Following Neoadjuvant Chemotherapy and Radical Cystectomy For Muscle-Invasive Bladder Cancer
SES AUA 2022: Primary Chemoablation of Low-Grade Intermediate-Risk Non-Muscle-Invasive Bladder Cancer Using UGN-102, A Mitomycin-Containing Reverse Thermal Gel (OPTIMA II): A Phase 2B, Open-Label, Single-Arm Trial
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free